This guide provides instructions for delivering the opioid overdose response and take home naloxone intervention to clients.​

Last updated: 04 November 2019
  1. Is the client eligible? Clients at risk of overdosing on illicit or pharmaceutical opioids (those currently using, have recently used, or are at risk of returning to using opioids after taking a break), likely to witness an overdose, are aged 16+, and contraindications (hypersensitivity) and precautions (pregnant/breastfeeding) have been considered.
  2. Introduce intervention to the client, describe its purpose (‘to help people respond to and prevent deaths from overdose’), likely duration of intervention (10-20 minutes), and involves the supply of ‘take home naloxone’.
  3. Assess and address client’s understanding of overdose: either unstructured (clinical assessment) or administer the client questionnaire and provide feedback using the Consumer Information Sheet.
  4. Discuss with client the choice between prefilled syringe for intramuscular injection or intranasal naloxone. Demonstrate the contents and use of Prenoxad® (injected) and Nyxoid® (intranasal).
  5. Health worker and client to complete the Checklist and Record of Supply form.
  6. Health worker to supply naloxone to client (client’s preferred formulation i.e. either nasal spray or pre-filled syringe if possible) in accordance with the Procedures, including labelling, and record in the Drug stock control sheet / imprest log book.
  7. File completed documents in client medical record (where patient medical record exists) or where no individual client medical records are maintained (e.g. NSP, outreach), file in an opioid overdose response and take home naloxone intervention folder at each participating site.
Page Updated: Monday 4 November 2019